Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy.

Hwang, Jessica P

Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. [electronic resource] - JCO clinical cancer informatics 03 2019 - 1-12 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

2473-4276

10.1200/CCI.18.00097 doi


Antineoplastic Agents--adverse effects
Cost-Benefit Analysis
Decision Making
Decision Trees
Hepatitis B--diagnosis
Hepatitis B virus--genetics
Humans
Immunosuppressive Agents--adverse effects
Mass Screening
Models, Theoretical
Neoplasms--complications
Quality of Life
Quality-Adjusted Life Years
SEER Program